<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1168">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 01, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01476228</url>
  </required_header>
  <id_info>
    <org_study_id>0394-11-HMO-CTIL</org_study_id>
    <nct_id>NCT01476228</nct_id>
  </id_info>
  <brief_title>EEG Objectification in Neuropsychiatry</brief_title>
  <official_title>EEG Objectification in Neuropsychiatry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to evaluate the use of EEG in the management and
      follow-up of neuropsychiatric disorders. Secondary objectives are therefore better
      understanding of the pathological activations in neural network during neuropsychiatric
      disorders, their clinical evolution and response to therapies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are having EEG recordings as a routine part of their clinical evaluation and
      diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical
      or electrical influence. It is of short duration and may be done in the EEG institute or the
      patient's room.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>percentage of fitting (0-100%) of EEG pattern to a previously identified electrophysiological &quot;key&quot;</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study will decode an EEG-based &quot;key&quot; (or electrophysiological pattern) for specific effect (such as the use of anti-epileptic agent or a certain condition) by comparing EEG before and after the use of this agent. For each patient the statistical fitting of the recorded EEG to the key will be evaluated by percentage (0-100%), describing fitting of the individual patient's EEG to the identified key.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Personality Disorder</condition>
  <condition>Depression</condition>
  <condition>Neurodegeneration</condition>
  <condition>Alzheimer's Disease</condition>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EEG recording</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG recording</intervention_name>
    <description>EEG recording</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of the investigated neuropsychiatric disease

        Exclusion Criteria:

          -  Other co-existing neuropsychiatric conditions

          -  Refusal to participate in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>shahar arzy, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HMO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>shahar arzy, MD PhD</last_name>
    <email>shahar.arzy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>HMO</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shahar Arzy, MD PhD</last_name>
      <phone>97226777741</phone>
      <email>shahar.arzy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <results_reference>
    <citation>Arzy S, Collette S, Wissmeyer M, Lazeyras F, Kaplan PW, Blanke O. Psychogenic amnesia and self-identity: a multimodal functional investigation. Eur J Neurol. 2011 Dec;18(12):1422-5. doi: 10.1111/j.1468-1331.2011.03423.x. Epub 2011 May 7.</citation>
    <PMID>21554495</PMID>
  </results_reference>
  <results_reference>
    <citation>Arzy S, Allali G, Brunet D, Michel CM, Kaplan PW, Seeck M. Antiepileptic drugs modify power of high EEG frequencies and their neural generators. Eur J Neurol. 2010 Oct;17(10):1308-12. doi: 10.1111/j.1468-1331.2010.03018.x.</citation>
    <PMID>20402743</PMID>
  </results_reference>
  <verification_date>August 2011</verification_date>
  <lastchanged_date>November 17, 2011</lastchanged_date>
  <firstreceived_date>August 22, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Nerve Degeneration</mesh_term>
    <mesh_term>Personality Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
